Home2022-11-22T21:50:38+00:00

Developing next generation oncology medicines through:

Novel scientific approach focused on cell-to-cell communications to improve outcomes across multiple cancer types and stages

Building a pipeline of unique and proprietary biomarker targeted therapies

A leadership team with deep oncology experience and international recognition

Go to Top